Equivalent results for Zenith and Endurant devices for aneurysms with unfavorable necks.

Original title: Outcomes of Endovascular Aneurysm Repair with 2 different Endograft Systems With Suprarenal Fixation in Patients With Hostile Infrarenal Aortic Anatomy. Reference: George A. Antomiuo et al. Vascular Endovascular Surgery 47(1):9-18

The unfavorable or hostile anatomy of abdominal aortic aneurysms is a limitation of endovascular treatment and is related to complications after implantation such as migration, the presence of leaks, reoperation and an increase in mortality and morbidity. 

The latest devices have incorporated improvements that achieve a more precise implant, better adaptability to the tortuous anatomy, a better proximal superior sealing, etc. For this study, unfavorable neck was considered in the presence of at least one of the following characteristics: neck length 60 °. Other structures such as the presence of thrombus or calcification were recorded but not considered as a criterion for the inclusion of patients. 

We included a total of 60 patients of which 27 received Zenith, (Cook Corp, Indianapolis, Indiana), and 33 Endurant, (Medtronic Cardiovascular, Santa Rosa, California). Clinical and anatomical characteristics in both groups were similar. The only significant difference was the increased use of general anesthesia in the Zenith group. Successful implantation was achieved in all patients of both groups, without the necessity of emergency surgery or conversion. In the track 18 ± 14, (1-47), months for the Zenith group and 14 ± 8, (1-26), months for the Endurant group, no significant differences were observed in the presence of leaks (Zenith 7 patients versus Endurant 3 patients; p = 0.068), reoperation (Zenith 4 patients versus Endurant 0 patients, log-rank test, p = 0.041) or all-cause mortality (Zenith 7 patients versus Endurant 2 patients, P = 0.087).

Conclusion: 

Similar results in terms of free survival of any leak and all-cause mortality can be achieved with both devices when treating patients with abdominal aortic aneurysms and proximal unfavorable neck anatomy.

Commentary: 

This analysis shows that it was not only feasible and safe to treat patients with an unfavorable anatomy with these devices but it also provided a favorable evolution at the medium term. 

Courtesy Dr Carlos Fava.
Interventional Cardiologist.
Favaloro Foundation. Buenos Aires, Argentina.

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...